These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26175755)

  • 1. miRNA therapeutics in cardiovascular diseases: promises and problems.
    Nouraee N; Mowla SJ
    Front Genet; 2015; 6():232. PubMed ID: 26175755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in cardiovascular diseases.
    Li H; Zhan J; Chen C; Wang D
    Med Rev (2021); 2022 Apr; 2(2):140-168. PubMed ID: 37724243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA and Cardiovascular Diseases.
    Çakmak HA; Demir M
    Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes.
    Aghabozorgi AS; Ahangari N; Eftekhaari TE; Torbati PN; Bahiraee A; Ebrahimi R; Pasdar A
    J Cell Physiol; 2019 Dec; 234(12):21796-21809. PubMed ID: 31273798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory microRNAs as biomarkers of cancer.
    Kai K; Dittmar RL; Sen S
    Semin Cell Dev Biol; 2018 Jun; 78():22-36. PubMed ID: 29258963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDL and microRNA therapeutics in cardiovascular disease.
    Michell DL; Vickers KC
    Pharmacol Ther; 2016 Dec; 168():43-52. PubMed ID: 27595929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs in Heart Development and Disease.
    Lozano-Velasco E; Inácio JM; Sousa I; Guimarães AR; Franco D; Moura G; Belo JA
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of miRNAs on the Pathophysiology of Cardiovascular Diseases.
    Silva DCPD; Carneiro FD; Almeida KC; Fernandes-Santos C
    Arq Bras Cardiol; 2018 Nov; 111(5):738-746. PubMed ID: 30484515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MicroRNA in Body Fluids - Development of the Novel Plat Form for Cancer Therapeutics and Diagnosis].
    Takahashi RU; Prieto-Vila M; Kohama I; Ochiya T
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):899-905. PubMed ID: 30026410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
    Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G
    J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of therapeutic miRNA using polymer-based formulation.
    Ban E; Kwon TH; Kim A
    Drug Deliv Transl Res; 2019 Dec; 9(6):1043-1056. PubMed ID: 31049843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.
    Yang Y; Yu T; Jiang S; Zhang Y; Li M; Tang N; Ponnusamy M; Wang JX; Li PF
    Expert Opin Ther Pat; 2017 Sep; 27(9):1021-1029. PubMed ID: 28627982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.
    Bernardo BC; Ooi JY; Lin RC; McMullen JR
    Future Med Chem; 2015; 7(13):1771-92. PubMed ID: 26399457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory miRNAs as novel cancer biomarkers.
    Zhang J; Zhao H; Gao Y; Zhang W
    Biochim Biophys Acta; 2012 Aug; 1826(1):32-43. PubMed ID: 22440944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [microRNA and internal medicine: from pathophysiology to the new diagnostic and therapeutic procedures].
    Novak J; Souček M
    Vnitr Lek; 2016; 62(6):477-85. PubMed ID: 27485847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases.
    Katoh M
    Front Cell Dev Biol; 2014; 2():61. PubMed ID: 25364765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-30 and 145 as Targets for the Treatment of Cardiovascular Diseases: Therapeutic Feasibility and Challenges.
    Tolouei SEL; Curi TZ; Klider LM; Junior AG
    Curr Pharm Des; 2021; 27(37):3858-3870. PubMed ID: 33308116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of noncoding RNAs in cardiac ageing.
    Varghese LN; Schwenke DO; Katare R
    Front Cardiovasc Med; 2023; 10():1142575. PubMed ID: 37034355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.